Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.
Lev-Tzion R, Focht G, Lujan R, Mendelovici A, Friss C, Greenfeld S, Kariv R, Ben-Tov A, Matz E, Nevo D, Barak-Corren Y, Dotan I, Turner D. Lev-Tzion R, et al. Among authors: kariv r. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1263-e1282. doi: 10.1016/j.cgh.2021.12.026. Epub 2021 Dec 23. Clin Gastroenterol Hepatol. 2022. PMID: 34954338 Free PMC article.
[Surveillance of patients with inflammatory bowel diseases].
Moshkowitz M, Kariv R, Half B, Vilkin A, Levi Z, Niv Y, Dotan I; Section of Gastrointestinal Oncology of the Israeli Gastroenterological Association. Moshkowitz M, et al. Among authors: kariv r. Harefuah. 2011 Apr;150(4):389-91, 417. Harefuah. 2011. PMID: 22164923 Hebrew.
BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign.
Ben-Tov A, Banon T, Chodick G, Kariv R, Assa A, Gazit S; Collaborators of the Maccabi Institute for Research & Innovation COVID-19 Task Force. Ben-Tov A, et al. Among authors: kariv r. Gastroenterology. 2021 Nov;161(5):1715-1717.e1. doi: 10.1053/j.gastro.2021.06.076. Epub 2021 Jul 2. Gastroenterology. 2021. PMID: 34224740 Free PMC article. No abstract available.
Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN.
Gorelik Y, Freilich S, Gerassy-Vainberg S, Pressman S, Friss C, Blatt A, Focht G, Weisband YL, Greenfeld S, Kariv R, Lederman N, Dotan I, Geva-Zatorsky N, Shen-Orr SS, Kashi Y, Chowers Y; IIRN. Gorelik Y, et al. Among authors: kariv r. Gut. 2022 Feb;71(2):287-295. doi: 10.1136/gutjnl-2021-325185. Epub 2021 Aug 3. Gut. 2022. PMID: 34344783 Free PMC article.
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Shen B, et al. Among authors: kariv r. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):69-95. doi: 10.1016/S2468-1253(21)00214-4. Epub 2021 Nov 10. Lancet Gastroenterol Hepatol. 2022. PMID: 34774224 Review.
134 results